Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 052627/0315 | |
| Pages: | 10 |
| | Recorded: | 05/11/2020 | | |
| Attorney Dkt #: | DCP-073 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16617721
|
Filing Dt:
|
11/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/30/2020
| | | | |
|
Title:
|
USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA
|
|
|
Assignee
|
|
|
|
|
| 200 SMITH STREET |
| WALTHAM, MASSACHUSETTS 02451 |
|
|
Correspondence name and address
|
| |
GOODWIN PROCTER LLP
|
| |
100 NORTHERN AVENUE
|
| |
IP DOCKETING DEPT./7TH FL
|
| |
BOSTON, MA 02210
|
Search Results as of:
05/15/2024 06:56 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
